MeSH tree: V03.175
In low-resource settings, babies born with gastroschisis—a congenital condition in which the developing intestines extend outside the body through a hole in the abdominal wall—face life-threatening challenges.
Jul 31, 2025
0
9
A new study in the journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.
Jul 31, 2025
0
15
Rural oncologists reported the loss of expertise and professional support as key impacts of the departure of "linchpin colleagues," according to a new Dartmouth-led study published in the journal JCO Oncology Practice. The ...
Jul 21, 2025
0
11
Frailty is a medically defined condition in older adults that increases vulnerability to everyday stresses, leading to a higher risk of falls, hospitalization and loss of independence. Warning signs of frailty include:
Jul 16, 2025
0
70
A new bionic knee allows amputees to walk faster, climb stairs more easily, and adroitly avoid obstacles, researchers reported in the journal Science.
Jul 11, 2025
0
43
A global study led by researchers at the School of Clinical Sciences at Monash Health, Monash University, has found that clinical trials that share their raw data are significantly more likely to be trustworthy and well-conducted, ...
Jul 10, 2025
0
14
Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.
Jul 10, 2025
0
10
Over the last several months, a deep sense of unease has settled over laboratories across the United States. Researchers at every stage—from graduate students to senior faculty members—have been forced to shelve experiments, ...
Jul 7, 2025
0
12
Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature ...
Jun 26, 2025
0
46
The UK's National Institute for Health and Care Excellence (NICE) has declined to recommend two new Alzheimer's drugs for routine NHS use in England. While disappointing for some families affected by dementia, this decision ...
Jun 25, 2025
0
12
